Project Grant HT94252310337
Award Date
5/1/23
Completion Date
4/30/27
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...
The Defense Health Agency awarded a $1,107,001 Project Grant to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the DROSHA gene's role in regulating mesenchymal expression and chemosensitivity in Wilms tumor. The grant was awarded on September 30, 2023 and will run through September 29, 2026 under the Military Medical Research and Development program (CFDA 12.420). UT Southwestern, a component of the University of Texas System, will lead the...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The University of Texas Southwestern Medical Center was awarded a $1,639,837 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The 4-year grant, awarded on June 15, 2024, supports a research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" focused on advancing the diagnosis and treatment of neurodegenerative tauopathies. As a leading academic medical center, UT Southwestern will leverage its expertise in biomedical...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,486,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 4-year research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" with a period of performance from June 15, 2024 to June 14, 2028. Through this grant, UT Southwestern will conduct innovative biomedical research on tauopathies, a class of...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $324,452 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, titled "Targeting PARP1 Trapping to Overcome PARP Inhibitor Resistance for BRCAmut Ovarian Cancers," will support research aimed at developing new treatments for ovarian cancer in military populations. The funding will enable UT Southwestern, a leading academic...
The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...
The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...